ELV vs HUM
ELV and HUM side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ELVELEVANCE HEALTH, INC. | HUMHUMANA INC |
|---|---|---|
| Market cap | $88.03B | $48.16B |
| P/E (TTM) | 18.0 | 42.8 |
| P/B | 1.96 | 2.59 |
| P/S | 0.4x | 0.4x |
| Dividend yield | 1.74% | 0.89% |
| Revenue | $201.11B(TTM) | $137.20B(TTM) |
| Revenue growth (YoY) | 12.5% | 10.1% |
| Net income | $4.96B(TTM) | $1.13B(TTM) |
| Earnings growth (YoY) | -5.3% | -1.6% |
| EPS, diluted | $22.61(TTM) | $9.37(TTM) |
| EBIT margin | 3.6% | 2.1% |
| ROE | 12.6% | 6.4% |
| ROIC | 9.3% | 8.1% |
| 1y total return | +28.4% | +29.7% |
Figures from SEC filings · for reference only · not investment advice
$10,000 투자 성장: ELV vs HUM
| 지표 | ELV | HUM |
|---|---|---|
| 최종 가치 | $33.4K | $24.6K |
| 총수익률 | +233.5% | +146.1% |
| CAGR | +12.4% | +9.1% |
| 변동성 | 31.0% | 34.6% |
| 샤프 | 0.41 | 0.31 |
| 소르티노 | 0.57 | 0.43 |
| 최대 낙폭 | -50.4% | -69.9% |
공통 거래일 2600일 기준, 2016-05-02 → 2026-09-02 · 무위험수익률 3.92% (현재 단기 국채 금리, 고정 적용)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)